CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | -59.1% | 14,281 | -5.6% | 0.03% | -52.3% |
| Q4 2021 | $171,000 | -25.0% | 15,125 | -3.3% | 0.06% | -35.0% |
| Q3 2021 | $228,000 | +18.8% | 15,636 | -4.9% | 0.10% | +26.6% |
| Q2 2021 | $192,000 | -28.6% | 16,448 | -25.4% | 0.08% | -30.7% |
| Q1 2021 | $269,000 | -0.7% | 22,053 | +1.8% | 0.11% | +1.8% |
| Q4 2020 | $271,000 | +48.9% | 21,660 | +79.6% | 0.11% | +17.9% |
| Q3 2020 | $182,000 | -45.8% | 12,061 | -12.1% | 0.10% | -40.3% |
| Q2 2020 | $336,000 | – | 13,718 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |